GDF-15 and hepcidin as a therapeutic target for anemia in chronic kidney disease.

"Declarations Ethics approval and consent to participateThis study was approved by Minia faculty of medicine ethical committee. Written informed consent was obtained from all participants and from a parent and/or legal guardian for those who are under 16. Methods were performed in accordance with the ethical standards as laid down in the Declaration of Helsinki and its later amendments or comparable ethical standards. Consent for publicationNot applicable. Competing interestsThe authors declare that they have no competing interests. Competing interests The authors declare that they have no competing interests."

"Funding Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB). NO sources for fund, all the cost paid by the authors.NO financial support or other benefits from commercial sources for the work reported on in the manuscript, No other financial interests of the authors,No conflict of interest with regard to the work."